Therapeutic drug monitoring of anti-tumour necrosis factor (TNF) may yield substantial savings in the costs of both inflammatory bowel disease and rheumatoid arthritis, without any negative effect on efficacy, according to the results of a systematic review.
The presence of several spondyloarthritis (SpA) features or fulfilment of the Assessment of SpondyloArthritis International Society (ASAS) does not automatically establish a diagnosis of axial SpA, according to a recent study, suggesting that positive imaging is particularly important for making a diagnosis.
The oral Janus kinase 1 inhibitor filgotinib produces rapid improvements in the signs and symptoms of active rheumatoid arthritis when used either alone or in combination with methotrexate, two 24-week phase IIb trials suggest.
Lupus myocarditis (LM) is a severe symptom of systemic lupus erythematosus (SLE), according to a new study, adding that LM can be the first indication of the disease or can occur during follow-up, particularly in untreated patients.
Cardiopulmonary exercise testing (CPET) appears to have potential utility in the noninvasive detection of systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH), with a new study suggesting that the method may particularly reduce unnecessary right heart catheterisation (RHC) procedures.
The new tool to identify cases of systemic autoimmune rheumatic diseases (SARD) has shown sensibility and validity, according to a recent study, adding that the use of both screening and confirmatory questions improves its accuracy.
Single-nucleotide polymorphisms (SNP) associated with rheumatoid arthritis (RA), as a group, are not related with coronary artery disease (CAD), according to a new study.
The intra-articular steroid preparation methylprednisolone acetate is as effective as triamcinolone acetonide in the treatment of chronic inflammatory arthritis, according to the results of a trial.
Erectile dysfunction may potentially be associated with gout, a new systematic report and meta-analysis reveals. However, the low quality and high degree of heterogeneity among the studies included reduce the certainty of this conclusion.
Patients with early arthritis should be allowed to share in the decision making regarding the approach to treatment, with rheumatologists acting as the primary specialists, according to the 2016 update of the European League Against Rheumatism (EULAR) recommendations for early arthritis management.